RecruitingPhase 2NCT06987539

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

Studying Adult-onset myasthenia gravis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Amgen
Principal Investigator
MD, MD
Amgen
Intervention
Inebilizumab(drug)
Enrollment
15 enrolled
Eligibility
2-17 years · All sexes
Timeline
2026 – 2030

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06987539 on ClinicalTrials.gov

Other trials for Adult-onset myasthenia gravis

Additional recruiting or active studies for the same condition.

See all trials for Adult-onset myasthenia gravis →

← Back to all trials